Form 4: Arcellx Director, Kavita Patel, Executes Stock Option and Sells Shares Under 10b5-1 Plan

Arcellx director, Kavita Patel, exercised stock options and sold shares on January 14, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Kavita Patel, a director at Arcellx, Inc., executed a stock option to acquire 1,500 shares of common stock at a price of $6.66 per share on January 14, 2025.
• On the same day, Ms. Patel sold a total of 1,500 shares of common stock in multiple transactions.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan established on March 28, 2024.
• The sales were conducted at weighted average prices of $64.9465 for 800 shares, $66.6225 for 400 shares, and $67.3167 for 300 shares.
• Following these transactions, Ms. Patel still beneficially owns 37,577 derivative securities.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives and directors of publicly traded companies, such as those in the biotechnology sector like Amgen, Gilead, and Regeneron, to manage their personal finances while avoiding potential insider trading issues.
• The vesting schedule of the stock options, with 25% vesting after one year and the remainder vesting monthly, is a typical structure for equity grants in the industry, similar to what is seen at companies like Moderna and BioNTech.
• The weighted average sale prices are within the expected range for the company's stock price at the time of the transaction, and the reporting of these prices is consistent with SEC requirements for insider transactions.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of a pre-planned trading strategy.

Key Dates

Keywords

Arcellx, stock options, 10b5-1 trading plan, insider trading, share sales, Kavita Patel, equity incentive plan